Back
Amplify Lithium & Battery Technology ETF Vs. Novo Nordisk AS Industry Stock Comparison
Sell
50
BATT
Amplify Lithium & Battery Technology ETF
Last Price:
$8.95
Seasonality Move:
-5.78%
Sell
25
NVO
Novo Nordisk AS
Last Price:
$85.63
Seasonality Move:
6.4%
Sell
50
Amplify Lithium & Battery Technology ETF (BATT)
is a Sell
Is Amplify Lithium & Battery Technology ETF a Buy, Sell or Hold?
-
The current Amplify Lithium & Battery Technology ETF [BATT] share price is $8.94. The Score for BATT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BATT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BATT Stock Price Chart
What is Amplify Lithium & Battery Technology ETF's stock price today?
-
The Amplify Lithium & Battery Technology ETF share price today is $8.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BATT is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.64The current trend is relatively stagnant and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BATT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 43.2 | Sell |
Chaikin Money Flow: | -14980 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.99 - 9.45) | Sell |
Bollinger Bands (100): | (8.61 - 9.57) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.06 | Sell |
Relative Strength Index (14 RSI): | 31.71 | Sell |
Chaikin Money Flow: | 6521757 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.72 - 109.1) | Sell |
Bollinger Bands (100): | (99.51 - 129.55) | Sell |
BATT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9 | Sell |
20-day SMA: | 9.19 | Sell |
50-day SMA: | 9.28 | Sell |
200-day SMA: | 9.1 | Sell |
8-day EMA: | 9.04 | Sell |
20-day EMA: | 9.13 | Sell |
50-day EMA: | 9.2 | Sell |
200-day EMA: | 9.32 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.04 | Sell |
20-day SMA: | 94.95 | Sell |
50-day SMA: | 102.54 | Sell |
200-day SMA: | 123.74 | Sell |
8-day EMA: | 86.81 | Sell |
20-day EMA: | 92.64 | Sell |
50-day EMA: | 101.62 | Sell |
200-day EMA: | 114.8 | Sell |
Amplify Lithium & Battery Technology ETF Earnings Growth & BATT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.
Amplify Lithium & Battery Technology ETF Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |